Novel way to develop tumor vaccines
Scientists at the University of Southern California (USC) have uncovered a new way to develop more effective tumor vaccines by turning off the suppression function of regulatory T cells. The results of the study, titled A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression, will be published in Nature Medicine on March 2, 2008……..
Original post by Health news from medicineworld.org
No comments yet. Be the first.
Leave a reply
Novel way to develop tumor vaccines
Scientists at the University of Southern California (USC) have uncovered a new way to develop more effective tumor vaccines by turning off the suppression function of regulatory T cells. The results of the study, titled A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression, will be published in Nature Medicine on March 2, 2008……..
Original post by Health news from medicineworld.org
No comments yet. Be the first.
Leave a reply